ENCELTO: payments to doctors
Payments that named ENCELTO as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $326K
- Providers
- 20
- Transactions
- 59
- Average per transaction
- $5,519
The per-transaction average — $5,519 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 20 providers the average total is $16,280, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Neurotech Pharmaceuticals, Inc. | $325,595 | 100.0% |